Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patients (Q37178648)

From Wikidata
Jump to navigation Jump to search
scientific article published on 21 July 2009
edit
Language Label Description Also known as
English
Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patients
scientific article published on 21 July 2009

    Statements

    Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patients (English)
    0 references
    Thomas Schwaab
    Adrian Schwarzer
    Todd S Crocenzi
    John D Seigne
    Nancy A Crosby
    Bernard F Cole
    Jan L Fisher
    Jill C Uhlenhake
    Diane Mellinger
    Cathy Foster
    Zbigniew M Szczepiorkowski
    Susan M Webber
    Alan R Schned
    Robert D Harris
    Richard J Barth
    John A Heaney
    Randolph J Noelle
    Marc S Ernstoff
    21 July 2009
    4986-4992

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit